[Efficacy of benazepril after failure of the first antihypertensive treatment].

The aim of the study was to evaluate efficacy of benazepril prescribed as replacement therapy in patients with mild to moderate hypertension, according to the pharmacological class of the previous unsuccessful drug. After wash-out of the ineffective or badly tolerated medication, 814 patients were randomly and blindly assigned to receive either benazepril 10 mg (group 1), benazepril 20 mg (group 2) or benazepril 10 mg plus hydrocholorothiazide 12.5 mg (group 3) once daily. The mean DBP changes from baseline were highly significant in each group (p < 0.001), and greater in groups 2 and 3 versus group 1 (p = 0.003). There was a non-significant trend for a greater efficacy of benazepril when the previous therapy was a diuretic or a calcium inhibitor. In this study, benazepril appears to be efficient as replacement therapy in moderate hypertension, but no link was demonstrated between the quality of the result and the nature of the previous drug.
AuthorsA Francillon, F Heintzmann, D Serrurier
JournalThérapie (Therapie) 1994 Mar-Apr Vol. 49 Issue 2 Pg. 95-9 ISSN: 0040-5957 [Print] FRANCE
Vernacular TitleEfficacité du bénazépril après échec d'un premier traitement antihypertenseur.
PMID7817356 (Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Benzazepines
  • benazepril
  • Adult
  • Angiotensin-Converting Enzyme Inhibitors (administration & dosage, therapeutic use)
  • Antihypertensive Agents (classification, therapeutic use)
  • Benzazepines (administration & dosage, therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: